These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 33220249)

  • 21. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.
    Yki-Järvinen H
    Lancet Diabetes Endocrinol; 2014 Nov; 2(11):901-10. PubMed ID: 24731669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of uric acid levels with components of metabolic syndrome and non-alcoholic fatty liver disease in overweight or obese children and adolescents.
    Cardoso AS; Gonzaga NC; Medeiros CC; Carvalho DF
    J Pediatr (Rio J); 2013; 89(4):412-8. PubMed ID: 23791233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New trends in non-alcoholic fatty liver diseases (NAFLD)].
    Barigou M; Favre L; Fraga M; Artru F
    Rev Med Suisse; 2020 Mar; 16(687):586-591. PubMed ID: 32216182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B.
    Han E; Lee YH; Kim BK; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH; Kim SU
    Aliment Pharmacol Ther; 2018 Aug; 48(3):300-312. PubMed ID: 29920701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Non-alcoholic fatty liver disease - a summary and update based on the EASL-EASD-EASO Clinical Practice Guidelines of 2016].
    Nádasdi Á; Somogyi A; Igaz P; Firneisz G
    Orv Hetil; 2018 Nov; 159(45):1815-1830. PubMed ID: 30415572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocrine and metabolic disorders interplaying with non-alcoholic fatty liver disease.
    Polyzos SA
    Minerva Endocrinol; 2017 Jun; 42(2):89-91. PubMed ID: 27792216
    [No Abstract]   [Full Text] [Related]  

  • 27. Current and Emerging Therapies for Non-alcoholic Fatty Liver Disease.
    Patel SS; Siddiqui MS
    Drugs; 2019 Jan; 79(1):75-84. PubMed ID: 30588564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation.
    Carter D; Dieterich DT; Chang C
    Clin Liver Dis; 2018 Feb; 22(1):213-227. PubMed ID: 29128058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between pancreas steatosis and the risk of metabolic syndrome and insulin resistance in Chinese adolescents with concurrent obesity and non-alcoholic fatty liver disease.
    Chiyanika C; Chan DFY; Hui SCN; So HK; Deng M; Yeung DKW; Nelson EAS; Chu WCW
    Pediatr Obes; 2020 Sep; 15(9):e12653. PubMed ID: 32351030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease.
    Souza MR; Diniz Mde F; Medeiros-Filho JE; Araújo MS
    Arq Gastroenterol; 2012; 49(1):89-96. PubMed ID: 22481692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease.
    Hussain A; Vasas P; El-Hasani S
    Metabolism; 2020 Jul; 108():154256. PubMed ID: 32360211
    [No Abstract]   [Full Text] [Related]  

  • 32. Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier?
    Dietrich CG; Geier A; Merle U
    World J Gastroenterol; 2023 Jan; 29(2):367-377. PubMed ID: 36687116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases.
    Eslam M; Ahmed A; Després JP; Jha V; Halford JCG; Wei Chieh JT; Harris DCH; Nangaku M; Colagiuri S; Targher G; Joshi S; Byrne CD; Khunti K; Nguyen MH; Gish RG; George J
    Lancet Gastroenterol Hepatol; 2021 Sep; 6(9):743-753. PubMed ID: 34265276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 Coagulopathy with Superior Mesenteric Vein Thrombosis Complicated by an Ischaemic Bowel.
    Fan BE; Chang CCR; Teo CHY; Yap ES
    Hamostaseologie; 2020 Dec; 40(5):592-593. PubMed ID: 32894875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease.
    Jung HN; Jung CH
    Diabetes Metab J; 2023 Mar; 47(2):198-200. PubMed ID: 36944452
    [No Abstract]   [Full Text] [Related]  

  • 36. Insulin resistance and metabolic syndrome in nonobese Indian patients with non-alcoholic fatty liver disease.
    Bhat G; Baba CS; Pandey A; Kumari N; Choudhuri G
    Trop Gastroenterol; 2013; 34(1):18-24. PubMed ID: 23923370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatty liver now, diabetes and heart attack later? The liver as a barometer of metabolic health.
    Chitturi S; Farrell GC
    J Gastroenterol Hepatol; 2007 Jul; 22(7):967-9. PubMed ID: 17608841
    [No Abstract]   [Full Text] [Related]  

  • 38. Indian College of Physicians Position Statement on Anemia in Metabolic Syndrome.
    Sahay M; Kalra S; Tiwaskar M; Ghosh S; Badani R; Bantwal G; Das AK; Dhorepatil B; Jeloka T; Khandelwal D; Nadkar MY; Saboo B; Sahay R; Unnikrishnan AG; Aggarwal S; Agrawal N; Bajaj S; Baruah MP; Chadha M; Das S; Dhamija P; Julka S; Mehta P; Shah SN; Sharma B; Muruganathan A
    J Assoc Physicians India; 2017 Jun; 65(6):60-73. PubMed ID: 28782315
    [No Abstract]   [Full Text] [Related]  

  • 39. Non-alcoholic fatty liver disease as a cause and consequence of cardio-metabolic complications. Role of the ursodeoxicholic acid in the pharmacotherapy.
    Maevskaya MV; Ivashkin VT; Ivashkin KV; Lunkov VD; Liusina EO; Zozula VN; Leshchenko VI
    Ter Arkh; 2019 Mar; 91(2):109-117. PubMed ID: 31094181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The Development of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease].
    Kwon OS; Kim JH; Kim JH
    Korean J Gastroenterol; 2017 Jun; 69(6):348-352. PubMed ID: 28637103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.